EnglishDIECI, Maria Vittoria
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Tumori ginecologici | 2012 | PF Conte; E Barbieri; V Guarneri; F Piacentini; MV Dieci |
| 2 | Timing for starting second line therapy in recurrent ovarian cancer. | 2011 | Guarneri, Valentina; Barbieri, Elena; Dieci, Maria Vittoria; Piacentini, Federico; Conte, Pierfranco |
| 3 | Survival in Hormone Receptor Positive/HER2 Negative Breast Cancer Patients Treated with Preoperative Chemotherapy. | 2010 | Barbieri E; Piacentini F; Dieci MV; Ficarra G; Conte PF; Guarneri V |
| 4 | Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities | 2014 | Dieci, Maria Vittoria; Orvieto, Enrico; Dominici, Massimo; Conte, Pierfranco; Guarneri, Valentina |
| 5 | Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact | 2014 | Dieci, Maria Vittoria; Piacentini, Federico; Dominici, Massimo; Omarini, Claudia; Goubar, Aicha; Ficarra, Guido; Conte, Pierfranco; Guarneri, Valentina |
| 6 | Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer | 2012 | Guarneri, Valentina; Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Omarini, Claudia; Ficarra, G.; Bettelli, Stefania Raffaella; Conte, Pierfranco |
| 7 | Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence | 2013 | Dieci, Maria Vittoria; Barbieri, Elena; Aicha, Goubar; Andre, Fabrice; Omarini, Claudia; Bettelli, Stefania Raffaella; Piacentini, Federico; Guido, Ficarra; Pier, Franco Conte; Guarneri, Valentina |
| 8 | Preoperative carboplatin-paclitaxel-bevacizumab in triple negative breast cancer: Final results of the phase II CA.Pa.Be study | 2013 | Guarneri, V; Boni, C; Puglisi, F; Cagossi, K; Piacentini, F; Bisagni, G; Dieci, Mv; Barbieri, E; Vicini, R; Conte, P |
| 9 | Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. | 2012 | Dieci, Maria Vittoria; Barbieri, Elena; Bettelli, Stefania Raffaella; Piacentini, Federico; Omarini, Claudia; Ficarra, G; Balduzzi, Sara; Dominici, Massimo; Conte, Pierfranco; Guarneri, Valentina |
| 10 | MANAGEMENT OF ADVANCED BREAST CANCER: HOW TO INTEGRATE SCIENTIFIC DATA AND CLINICAL JUDGMENT | 2012 | Conte, P.; Dieci, M. V.; Piacentini, F. |
| 11 | Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer | 2011 | Guarneri, Valentina; Pecchi, A; Piacentini, Federico; Barbieri, Elena; Dieci, Mv; Ficarra, G; Tazzioli, Giovanni; Frassoldati, A; Battista, R; Canossi, B; Mauri, C; D'Amico, Roberto; Conte, Pierfranco; Torricelli, Pietro |
| 12 | Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients | 2013 | Guarneri, V; Dieci, Mv; Barbieri, E; Piacentini, F; Omarini, C; Ficarra, G; Bettelli, S; Conte, P |
| 13 | Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer | 2016 | Musolino, A; Naldi, N; Dieci, Maria Vittoria; Zanoni, Daniele; Rimanti, Anita; Boggiani, D; Sgargi, P; Generali, Dg; Piacentini, Federico; Ambroggi, M; Cagossi, K; Gianni, L; Sarti, S; Bisagni, G; Ardizzoni, Andrea; Conte, Pf; Guarneri, Valentina |
| 14 | Immune characterization of breast cancer metastases: prognostic implications. | 2018 | Dieci, Mv; Tsvetkova, V; Orvieto, E; Piacentini, F; Ficarra, G; Griguolo, G; Miglietta, F; Giarratano, T; Omarini, C; Bonaguro, S; Cappellesso, R; Aliberti, C; Vernaci, G; Giorgi, Ca; Faggioni, G; Tasca, G; Conte, P; Guarneri, V. |
| 15 | Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis | 2012 | Dieci MV; Barbieri E; Piacentini F; Ficarra G; Bettelli S; Dominici M; Conte PF; Guarneri V. |
| 16 | COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS | 2008 | Guarneri, V.; Giovannelli, S.; Ficarra, G.; Bettelli, S.; Piacentini, F.; Barbieri, E.; Dieci, Mv.; Jovic, G.; Conte, Pf. |
| 17 | Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management | 2008 | Guarneri, Valentina; Giovannelli, Simona; Ficarra, G; Bettelli, Stefania Raffaella; Maiorana, Antonino; Piacentini, Federico; Barbieri, Elena; Dieci, Maria Vittoria; D'Amico, Roberto; Jovic, Gordana; Conte, Pierfranco |
| 18 | Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts | 2011 | Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Ficarra, G; Bettelli, Stefania Raffaella; Conte, Pierfranco; Guarneri, Valentina |
| 19 | Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer | 2010 | Guarneri, Valentina; Barbieri, Elena; Dieci, Mv; Piacentini, Federico; Conte, Pierfranco |
| 20 | 37. KI67 AS A PREDICTOR OF RESPONSE AND LONG TERM SURVIVAL IN HORMONE RECEPTOR POSITIVE/HER2 NEGATIVE BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY | 2010 | Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Ficarra, Guido; Conte, Pierfranco; Guarneri, Valentina |
Nome completo:
DIECI, Maria Vittoria
Copyright © 2019